News

Ophthalmology Times5h
ARVO 2025: In vivo imaging of RPE metabolic function in AMD
At ARVO 2025, in Salt Lake City, Utah, Xiaolin Wang, MS, talked about her presentation on in vivo imaging of retinal pigment ...
Ophthalmology Times14h
FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Ophthalmology Times12h
ARVO 2025: 12-month results in myopic children using combination treatment of atropine and DIMS spectacle lenses
Villahoz, MD, PhD, talked about 12-month results of vision-related quality of life in myopic children using combination ...
Ophthalmology Times9h
Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...
Ophthalmology Times10h
NASA astronauts to keynote 2025 Internatioal SPECTRALIS Symposium in Heidelberg
Join global experts at the 2025 International SPECTRALIS Symposium in Heidelberg, exploring innovations in ophthalmology and ...
Ophthalmology Times16h
Q&A: Matthew Starr, MD, shares insights into RHONE-X trial
Matthew Starr, MD, highlights the RHONE-X trial's findings on faricimab, showcasing improved vision and reduced treatment ...
Ophthalmology Times12h
Noemi Guemes-Villahoz, MD, PhD
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.